Aug 2026
Development of Wogonin Nanoliposomes Using Box–Behnken Design Optimization: In Vitro Anticancer Activity Evaluation and Cell Cycle Analysis
A three-factor, three-level Box–Behnken Design-optimized Wogonin-NL constitutes a physico-chemically well-defined, biologically active nanoliposomal platform with cancer-preferential cytotoxicity and a validated stability profile.
Amulya Ch, Shailaja P
· Journal of Pharmaceutical In... · 0 citations